跳至主要内容
临床试验/NCT06314386
NCT06314386Enrolling By Invitation不适用

SAIA-TB: Using the Systems Analysis and Improvement Approach (SAIA) to Prevent TB in Rural South Africa

Boston College16 个研究点 分布在 1 个国家目标入组 19,560 人开始时间: 2025年2月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
19,560
试验地点
16
主要终点
TB Screening

研究概览

简要总结

This randomized trial uses the evidence-based Systems Analysis and Improvement Approach (SAIA) adapted for tuberculosis (SAIA-TB) to assess the comprehensive tuberculosis (TB) care cascade across 16 clinics in rural Eastern Cape, South Africa to improve patient outcomes. The aims of this study are to:

  • Evaluate the effectiveness of SAIA-TB use in clinics on TB cascade outcomes for TB patients and with high-risk contacts
  • Determine the drivers of SAIA-TB implementation success or failure across clinics

The investigators hypothesize that SAIA-TB implementation will lead to a 20% increase in each of: TB screening, TB preventive treatment initiation, and TB disease treatment initiation during the 18-month intervention period.

详细描述

This four-wave stepped wedge crossover cluster randomized trial will assess the effectiveness of the SAIA-TB intervention (Aim 1). A total of 16 clinics in four municipalities within the Sarah Baartman-district, Eastern Cape, South Africa will be included. The SAIA-TB intervention will be implemented at the clinic level. Public sector clinic staff and clinic managers, supported by study personnel, will deliver the intervention over an 18-month implementation phase, followed by a 12-month maintenance phase led by clinic managers without additional study personnel support, to provide evidence on intervention impact under ideal circumstances, as well as sustained effect over time. Aim 2 will consist of interviews and using the organization readiness for implementing change (ORIC) with facilities early in SAIA-TB implementation (within 3 months of initiating the intervention) to identify clinic-level attributes that affect intervention adoption. Additionally, the Consolidated Framework for Implementation Research (CFIR) will guide data collection and interpretation related to implementation, assess fidelity to intervention protocol, describe intervention adaptations when integrated into routine management systems, and identify clinic-level determinants of successful SAIA-TB implementation. Recurrent measurement of structural readiness and implementation dose (as a function of quality and quantity) at the clinic level will inform guidance on essential structural needs to implement SAIA-TB. The trial will culminate in a dissemination package, summarizing results and providing implementation guidance to support scale-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older
  • Frontline clinical and/or managerial staff, district-level TB management
  • Ability to provide informed consent

排除标准

  • Under age 18
  • Unwilling to provide informed consent

研究组 & 干预措施

Exposed

Other

Clinics are considered exposed after intensive SAIA-TB intervention, implementation phase, and maintenance phase.

干预措施: Systems Analysis and Improvement Approach for TB (SAIA-TB) (Other)

Unexposed

No Intervention

Clinics are considered unexposed prior to the initiation of SAIA-TB in their clinic

结局指标

主要结局

TB Screening

时间窗: 18 months

The proportion of individuals screened with WHO TB symptom screen in the target population

Linkage to care for TB disease treatment

时间窗: 18 months

The proportion of individuals initiating TB disease treatment among those with a positive diagnostic evaluation

Linkage to care for TB preventive treatment

时间窗: 18 months

The proportion of individuals initiating TB preventive treatment among those with a negative diagnostic evaluation and eligible for TPT

次要结局

  • Successful TB Prevention Treatment (TPT) Outcome(18 months)
  • TB Evaluation(18 months)
  • TB Diagnosis(18 months)
  • Successful TB Outcome(18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验